Registration Dossier

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Additional information

Hydroxypropinol (ZK 4829) did not show a mutagenic potential in a bacterial reverse mutation assay (S. typhimurim strains TA 1535, TA 100, TA 1537, TA 1538 and TA98) when tested up to the maximum recommended dose level of 5 mg/plate in the absence and presence of extrinsic metabolic activation (liver S9 mix from Aroclor 1254 -treated rats). Growth inhibition as well as precipitates in the agar were seen at 5.0 mg/plate.

Short description of key information:
Gene mutation (Ames-Test, OECD TG471): negative with and without metabolic activation
[Schering AG, Report No. X512 -draft-, 2001-01-30]

Endpoint Conclusion: No adverse effect observed (negative)

Justification for classification or non-classification

Based on the results there is no classification required according to Directive 67/548/EEC and Regulation (EC) 1272/2008 (CLP).